Test Price
2,800 AED✅ Home Collection Available
CCDC50 Gene (Deafness, Autosomal Dominant Type 44) Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑Accredited NGS Processing.
- Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection & VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in Result Interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The CCDC50 gene test uses Next‑Generation Sequencing (NGS) to fully analyze the coding region of the CCDC50 gene, the definitive cause of autosomal dominant nonsyndromic hearing loss type DFNA44. This advanced molecular analysis ensures comprehensive detection of single nucleotide variants, insertions, deletions, and copy number variations across the entire gene, achieving a 99.9% diagnostic sensitivity threshold.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Method | NGS – Full gene sequencing with copy number analysis | Sanger sequencing of known hotspots only |
| Precision | 99.9% sensitivity, covering rare & novel variants | May miss non‑hotspot pathogenic mutations |
| Turnaround Time | 21–28 business days (3–4 weeks) | 6–8 weeks (typical local panel) |
Physician Insight & Safety Protocols
“As a consultant medical geneticist, I recognize the profound impact that precise genetic diagnosis has on families facing hereditary hearing loss. This targeted NGS analysis of the CCDC50 gene delivers rapid, high‑accuracy results that empower clinicians to plan early interventions and provide informed reproductive counseling. Results must always be interpreted alongside a comprehensive audiological and clinical evaluation.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA License: 9294403
Medication Advisory
⚠️ Do not discontinue any prescribed medication without consulting your treating physician. This test does not replace professional medical judgment.
Pre‑Test Exclusion Criteria & Red Flags
- Recent blood transfusion or bone marrow transplant within the last 12 weeks – may compromise germline DNA result.
- Active fever, acute infection, or uncontrolled bleeding disorder at the time of home collection.
- Inability to provide a blood sample (infants – alternative buccal swab may be arranged separately).
- Emergency Red Flag: If you experience sudden, complete hearing loss accompanied by vertigo, tinnitus, or neurological symptoms, proceed to the nearest Emergency Department immediately. This test is elective and does not replace acute care.
Patient FAQ & Clinical Guidance
1. What exactly does the CCDC50 genetic test detect?
This advanced NGS test sequences the entire CCDC50 gene to identify disease‑causing mutations linked to autosomal dominant deafness type 44 with 99.9% accuracy. It detects single nucleotide variants, insertions, deletions, and copy number variations that are causative for DFNA44.
2. How is the sample collected and is home collection truly hospital‑grade?
A DHA‑licensed phlebotomist arrives at your doorstep to draw a small blood volume or a drop on an FTA card, using an ISO‑certified cold‑chain transport process ensuring sample integrity. This VIP Mobile Phlebotomy service is available daily from 8 AM to 11 PM.
3. What happens after I receive my results?
A post‑test clinical guidance call is scheduled with our genetic counseling team to interpret the report, explain implications for family members, and plan appropriate audiological follow‑up. This service is included in the test price.
4. Is this test covered by insurance?
Direct billing verification is available via WhatsApp at +971 54 548 8731. Coverage depends on your individual policy; our team can assist with prior authorization queries.
UAE Regulatory & Data Privacy Adherence
All genetic testing and personal data handling comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
DNA Labs UAE holds DHA Facility License No. 1143 and operates from Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. Your genetic data is encrypted, anonymized for research only with explicit consent, and never shared with third parties without your authorization.
Clinical & Logistical Metadata
| Test Name | CCDC50 Gene (Deafness, Autosomal Dominant Type 44) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 21–28 business days (3–4 weeks) |
| Sample Type / Matrix | Whole Blood (Peripheral) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily 8 AM – 11 PM) |
| Methodology Used | Next-Generation Sequencing (NGS) – Full Gene Sequencing with CNV Analysis |
| ICD-10-CM Code | H90.3 (Sensorineural hearing loss, bilateral) |
| LOINC Code | 81287-4 (CCDC50 gene mutation analysis in blood) |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians